Stock CNXC CONCENTRIX CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials Concentrix Corporation

Equities

CNXC

US20602D1019

Business Support Services

Market Closed - Nasdaq
Other stock markets
 02:00:00 04/05/2024 am IST 		5-day change 1st Jan Change
59.35 USD +3.61% Intraday chart for Concentrix Corporation +7.89% -39.57%
28/03 North American Morning Briefing : Stocks Set for -2- DJ
27/03 BofA Securities Downgrades Concentrix to Underperform From Neutral MT

Valuation

Fiscal Period: November 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 4,136 8,670 6,243 6,260 3,917 - -
Enterprise Value (EV) 1 4,136 8,670 6,243 10,907 8,785 8,041 7,192
P/E ratio 25.1 x 21.6 x 14.8 x 16.5 x 12.3 x 8.74 x -
Yield - 0.15% 0.84% - 2.04% 2.17% 2.63%
Capitalization / Revenue 0.88 x 1.55 x 0.99 x 0.88 x 0.41 x 0.39 x 0.38 x
EV / Revenue 0.88 x 1.55 x 0.99 x 1.53 x 0.92 x 0.81 x 0.7 x
EV / EBITDA 6.48 x 9.92 x 6.06 x 9.23 x 5.27 x 4.59 x 3.86 x
EV / FCF - - - 21.9 x 12.6 x 7.77 x 6.2 x
FCF Yield - - - 4.56% 7.91% 12.9% 16.1%
Price to Book - - - - - - -
Nbr of stocks (in thousands) 51,700 52,227 51,016 66,601 65,992 - -
Reference price 2 80.00 166.0 122.4 93.99 59.35 59.35 59.35
Announcement Date 11/01/21 18/01/22 19/01/23 24/01/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: November 2020 2021 2022 2023 2024 2025 2026
Net sales 1 4,720 5,587 6,324 7,115 9,600 9,929 10,338
EBITDA 1 638.5 874 1,031 1,182 1,668 1,753 1,864
EBIT 1 509.4 733.7 884.1 1,010 1,409 1,485 -
Operating Margin 10.79% 13.13% 13.98% 14.2% 14.68% 14.96% -
Earnings before Tax (EBT) 1 - 555.7 605 408.2 451.2 633.7 871.9
Net income 1 164.8 399.9 428.5 307.9 319.9 446.2 -
Net margin 3.49% 7.16% 6.77% 4.33% 3.33% 4.49% -
EPS 2 3.190 7.700 8.280 5.700 4.827 6.790 -
Free Cash Flow 1 - - - 497.5 695 1,035 1,160
FCF margin - - - 6.99% 7.24% 10.42% 11.22%
FCF Conversion (EBITDA) - - - 42.1% 41.67% 59.04% 62.23%
FCF Conversion (Net income) - - - 161.59% 217.26% 231.98% -
Dividend per Share 2 - 0.2500 1.025 - 1.210 1.290 1.560
Announcement Date 11/01/21 18/01/22 19/01/23 24/01/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: November 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 1,467 1,536 1,568 1,580 1,641 1,636 1,615 1,633 2,231 2,403 2,348 2,384 2,441 2,476 2,414
EBITDA 1 238.2 237.9 249.9 258.4 284.8 255.8 258.8 269.3 397.9 384.3 389.4 435 458.5 - -
EBIT 1 203.4 201.9 212.8 221.5 248 217.6 220.6 231 340.8 319.1 323.9 371.1 394.6 - -
Operating Margin 13.87% 13.14% 13.57% 14.02% 15.12% 13.3% 13.66% 14.15% 15.28% 13.28% 13.79% 15.57% 16.16% - -
Earnings before Tax (EBT) 1 154.9 146.6 146.5 149.4 162.6 118.3 106 106.8 77.11 72.82 79 138.3 161.1 - -
Net income 1 122.3 110.3 113.1 106.7 103.2 87.87 78.85 77.64 67.83 52.1 56.2 96.78 115.5 - -
Net margin 8.34% 7.18% 7.22% 6.75% 6.29% 5.37% 4.88% 4.75% 3.04% 2.17% 2.39% 4.06% 4.73% - -
EPS 2 2.350 2.090 2.140 2.040 2.010 1.680 1.510 1.490 1.090 0.7600 0.8467 1.463 1.753 - -
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 18/01/22 29/03/22 27/06/22 28/09/22 19/01/23 29/03/23 28/06/23 27/09/23 24/01/24 26/03/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: November 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - 4,647 4,869 4,124 3,275
Net Cash position 1 - - - - - - -
Leverage (Debt/EBITDA) - - - 3.932 x 2.919 x 2.352 x 1.757 x
Free Cash Flow 1 - - - 497 695 1,035 1,160
ROE (net income / shareholders' equity) 16.8% 21.4% 22.9% 18.1% 18.8% 19.5% 19.3%
ROA (Net income/ Total Assets) - - - - - - -
Assets 1 - - - - - - -
Book Value Per Share - - - - - - -
Cash Flow per Share 2 9.840 9.900 11.60 12.60 14.00 15.10 -
Capex 1 - - - 181 290 301 308
Capex / Sales - - - 2.54% 3.02% 3.03% 2.98%
Announcement Date 11/01/21 18/01/22 19/01/23 24/01/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Concentrix Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
59.35 USD
Average target price
87.8 USD
Spread / Average Target
+47.94%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Business Support Services

1st Jan change Capi.
CONCENTRIX CORPORATION Stock Concentrix Corporation
-39.57% 3.92B
CINTAS CORPORATION Stock Cintas Corporation
+11.84% 68.39B
JACOBS SOLUTIONS INC. Stock Jacobs Solutions Inc.
+14.09% 18.61B
BUREAU VERITAS SA Stock Bureau Veritas SA
+21.12% 13.54B
RB GLOBAL, INC. Stock RB Global, Inc.
+8.00% 13.22B
INTERTEK GROUP PLC Stock Intertek Group plc
+16.72% 10.03B
TELEPERFORMANCE SE Stock Teleperformance SE
-28.16% 6.2B
GENPACT LIMITED Stock Genpact Limited
-9.71% 5.65B
MAXIMUS, INC. Stock Maximus, Inc.
-1.25% 5.05B
EXLSERVICE HOLDINGS, INC. Stock ExlService Holdings, Inc.
-3.89% 4.82B
Other Business Support Services
  1. Stock Market
  2. Equities
  3. CNXC Stock
  4. Financials Concentrix Corporation
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW